Caricamento...
Blood Targets of Adjuvant Drugs Against COVID19
While waiting for the vaccine and/or the best treatment for COVID19, several drugs have been identified as potential adjuvant drugs to counteract the viral action. Several drugs, in fact, have been suggested for their ancillary antiviral role. Viral proteases and peptidases, may interact with well-k...
Salvato in:
| Pubblicato in: | J Blood Med |
|---|---|
| Autori principali: | , , , , , , , , |
| Natura: | Artigo |
| Lingua: | Inglês |
| Pubblicazione: |
Dove
2020
|
| Soggetti: | |
| Accesso online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7338832/ https://ncbi.nlm.nih.gov/pubmed/32694923 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/JBM.S256121 |
| Tags: |
Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !
|